Meda AB (STO:MEDAA):
The Nomination Committee of Meda AB proposes the election of Guido
Oelkers and Martin Svalstedt as new board members and proposes the
appointment of Martin Svalstedt as Board Chairman. The committee further
proposes the re-election of Peter Claesson, Peter von Ehrenheim,
Marianne Hamilton, Tuve Johannesson, Karen Sörensen and Lars Westerberg.
Former CEO and board member Anders Lönner stepped down from the board
when he stepped down from the position of CEO, and current Board
Chairman Bert Åke Eriksson has declined re-election to the board.
Guido Oelkers is currently CEO of BSN Group, Hamburg. Oelkers has
previous been CEO of Gambro AB and has experience from several global
assignments. He holds a Ph.D. in strategic management.
Martin Svalstedt is currently CEO of Adactum AB, Stena sphere's
investmen company, and is Board Chairman of Gunnebo AB and Ballingslöv
AB. Svalstedt holds a Master of Science in Business Administration and
The nomination committee for the AGM 2014 consists of Evert Carlsson
(Swedbank Robur Funds), Lars Backsell (B&E Participation AB), Anders
Oscarsson (AMF Funds), Bert Åke Eriksson (Meda's Chairman of the Board)
and Karl-Magnus Sjölin (Stena Sessan).
The nomination committee's other proposals concerning the chairman of
the meeting, remuneration and the method used to appoint the nomination
committee will be disclosed on the website and in the notice of the
Annual General Meeting.
The Annual General Meeting of Meda AB will be held on May 7, 2014 at
17.00 CET at Meda AB, Pipers väg 2A, Solna, Sweden.
MEDA AB (publ) is a leading international specialty pharma company.
Meda's products are sold in more than 120 countries worldwide and the
company is represented by its own organizations in over 55 countries.
The Meda share is listed under Large Cap on the Nasdaq OMX Nordic Stock
Exchange in Stockholm. Find out more, visit www.meda.se.
This information was brought to you by Cision http://news.cision.com
[ Back To NFVZone's Homepage ]